The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction: An Update
Abstract
Abstract—Plasma fibrinogen is a major determinant of platelet aggregation and blood viscosity. The decrease in plasma fibrinogen by bezafibrate is associated with a decrease in the risk of reinfarctions. To strengthen the predictive value of plasma fibrinogen with respect to cardiovascular risk, we performed a meta-analysis of studies conducted between 1984 and 1998. Emphasis has been put on the relationship between high levels of plasma fibrinogen and fatal and/or nonfatal cardiovascular events in both the general population and in patients with previous cardiovascular events. Twenty-two studies (13 prospective, 5 cross-sectional, and 4 case-control) addressing the association between fibrinogen plasma concentrations and cardiovascular disease were analyzed. The overall estimate of risk of cardiovascular event in subjects with plasma fibrinogen levels in the higher tertile, was twice as high as that of subjects in the lower one (odds ratio, 1.99; 95% confidence interval, 1.85 to 2.13). High plasma fibrinogen levels were associated with an increased risk of cardiovascular disease in healthy as much as in high-risk individuals. A metaregression showed no confounding effects attributable to selected characteristics of retrieved studies. A subgroup analysis (study design, follow up, mean fibrinogen levels, percentage of smokers, and mean age) allowed us to conclude that fibrinogen is an independent risk factor for cardiovascular disease; that it interacts with major determinants of myocardial and cerebrovascular ischemia; and that, in secondary prevention studies, it enhances by 8% the prediction of future events by established risk factors. Thus, fibrinogen measurements should be encouraged to refine the overall risk profiles of individuals and to better tailor preventive interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,109
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Davies, M. J., & Thomas, A. C. (1985) · Heart · doi:10.1136/hrt.53.4.363 · Cited by 1,985
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Meade, T. W., Brozovic, M., Chakrabarti, R. R., Haines, A. P., Imeson, J. D., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,939
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Prevention of coronary heart disease in clinical practice
PYÖRÄLÄ, K., BACKER, G. D., GRAHAM, I., POOLE-WILSON, P., & WOOD, D. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060388 · Cited by 1,163
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 731
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Some Statistical Methods for Combining Experimental Results
Laird, N. M., & Mosteller, F. (1990) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008916 · Cited by 568
Heinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563
Toss, H., Lindahl, B., Siegbahn, A., Wallentin, L., & Group, F. T. F. S. (1997) · Circulation · doi:10.1161/01.cir.96.12.4204 · Cited by 520
Ericsson, C.-G., de Faire, U., Grip, L., Svane, B., Hamsten, A., & Nilsson, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91343-4 · Cited by 426
&NA; (1996) · The Endocrinologist · doi:10.1097/00019616-199609000-00019 · Cited by 417
Balleisen, L., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657877 · Cited by 346
Tunstall-Pedoe, H., Woodward, M., Tavendale, R., Brook, R. A., & McCluskey, M. K. (1997) · BMJ · doi:10.1136/bmj.315.7110.722 · Cited by 317
CREMER, P., NAGEL, D., LABROT, B., MANN, H., MUCHE, R., ELSTER, H., & SEIDEL, D. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02373.x · Cited by 298
Koster, T., Rosendaal, F. R., Reitsma, P. H., Velden, P. A. V. D., Briët, E., & Vandenbroucke, J. P. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642511 · Cited by 293
Behague, I., Poirier, O., Nicaud, V., Evans, A., Arveiler, D., Luc, G., Cambou, J.-P., Scarabin, P.-Y., Bara, L., Green, F., et al. (1996) · Circulation · doi:10.1161/01.cir.93.3.440 · Cited by 282
Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction
Iacoviello, L., Di Castelnuovo, A., de Knijff, P., D'Orazio, A., Amore, C., Arboretti, R., Kluft, C., & Donati, M. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380202 · Cited by 278
Rosner, B., Spiegelman, D., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116453 · Cited by 261
A quick and accurate method for the determination of fibronogen in plasma.
Ellis, B., & Stransky, A. W. (1961) · PubMed · Cited by 249
Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the Moon
Maseri, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361409 · Cited by 228
Fowkes, F. G. R., Housley, E., Rattray, A., Lowe, G. D. O., Rumley, A., Elton, R. A., MacGregor, I. R., & Dawes, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91288-w · Cited by 192
Qizilbash, N., Jones, L., Warlow, C., & Mann, J. (1991) · BMJ · doi:10.1136/bmj.303.6803.605 · Cited by 184
Thomas, A. E., Green, F. R., Kelleher, C. H., Wilkes, H. C., Brennan, P. J., Meade, T. W., & Humphries, S. E. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648177 · Cited by 172
Meta-analysis in medicine Where we are and where we want to go
Jenicek, M. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90023-1 · Cited by 171
Bias in the one‐step method for pooling study results
Greenland, S., & Salvan, A. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090307 · Cited by 165
Lee, A. J., Lowe, G. D., Woodward, M., & Tunstall-Pedoe, H. (1993) · Heart · doi:10.1136/hrt.69.4.338 · Cited by 164
Measuring plasma fibrinogen to predict stroke and myocardial infarction.
Di Minno, G., & Mancini, M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.1.1 · Cited by 162
Self-citationWoodward, M., Lowe, G. D. O., Rumley, A., Tunstall‐Pedoe, H., Philippou, H., Lane, D. A., & Morrison, C. E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1232935.x · Cited by 156
Sweetnam, P. M., Thomas, H. F., YARNELL, J. W. G., Beswick, A. D., Baker, I. A., & Elwood, P. C. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014797 · Cited by 155
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1263 · Cited by 152
Woodward, M. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0573 · Cited by 149
Fibrinogen as a major risk factor in cardiovascular disease
Cook, N. S., & Ubben, D. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90125-r · Cited by 146
Fibrinogen and Viscosity as Risk Factors for Subsequent Cardiovascular Events in Stroke Survivors
Resch, K. L., Ernst, E., Matrai, A., & Paulsen, H. F. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-371 · Cited by 146
The pathogenesis of atherosclerosis
Ross, R. (1979) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(79)90084-8 · Cited by 138
Regulation of acute phase gene expression by inflammatory mediators.
Gh, F., & Fuller, G. M. (1987) · PubMed · Cited by 138
Fibrinogen genotype and risk of peripheral atherosclerosis
Fowkes, F. G. R., Smith, F. B., Donnan, P. T., Connor, J. M., Wood, J., & Lowe, G. D. O. (1992) · The Lancet · doi:10.1016/0140-6736(92)90596-u · Cited by 134
Scarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123
The determination of plasma fibrinogen by the clot-weight method
Ingram, G. I. C. (1952) · Biochemical Journal · doi:10.1042/bj0510583 · Cited by 123
Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease Patients
Benderly, M., Graff, E., Reicher-Reiss, H., Behar, S., Brunner, D., & Goldbourt, U. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.3.351 · Cited by 118
Invited Commentary: Re: “A Critical Look at Some Popular Meta-Analytic Methods”
Olkin, I. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117249 · Cited by 115
Fibrin as a factor in atherogenesis
Smith, E. B., & Thompson, W. D. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90049-3 · Cited by 97
Contribution of Factor VII Genotype to Activated FVII Levels
Bernardi, F., Arcieri, P., Bertina, R. M., Chiarotti, F., Corral, J., Pinotti, M., Prydz, H., Samama, M. M., Sandset, P. M., Strom, R., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2548 · Cited by 91
Meta-analysis: A method for synthesizing research*
D’Agostino, R. B., & WEINTRAUB, M. I. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90016-0 · Cited by 84
Wu, K. K., Folsom, A. R., HEISS, G. M., DAVIS, C. E., Conlan, M. G., & Barnes, R. W. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90097-a · Cited by 69
Cause of thrombosis in human atherosclerotic arteries
Constantinides, P. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90393-f · Cited by 62
Cappucci, G., Colaizzo, D., Pirro, L., Vecchione, G., Grandone, E., Minno, G. D., & Margaglione, M. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615362 · Cited by 48
Genetic variation at fibrinogen loci and plasma fibrinogen levels.
Connor, J. M., Fowkes, F. G. R., Wood, J., Smith, F. B., Donnan, P. T., & Lowe, G. D. O. (1992) · PubMed Central · Cited by 44
de Maat, M. P. M., de Knijff, P., Green, F. R., Thomas, A. E., Jespersen, J., & Kluft, C. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.856 · Cited by 44
Haemostatic factors and prevalent coronary heart disease; the FINRISK haemostasis study
Salomaa, V. V., Rasi, V., Pekkanen, J., Vahtera, E. M., Jauhiainen, M., Vartiainen, E., Myllylä, G., & Ehnholm, C. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060387 · Cited by 43
Sweetnam, P. M., YARNELL, J. W. G., Lowe, G. D. O., Baker, I. A., O'Brien, J. R., Rumley, A., Etherington, M. D., WHITEHEAD, P. J., & Elwood, P. C. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00604.x · Cited by 35
Plasma Fibrinogen and Coronary Heart Disease in Elderly Japanese-American Men
Sharp, D. S., Abbott, R. D., Burchfiel, C. M., Rodríguez, B. L., Tracy, R. P., Yano, K., & Curb, J. D. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.262 · Cited by 28
Meta-Analysis: A Review of its Place in Therapeutic Decision Making
Gibaldi, M. (1993) · Drugs · doi:10.2165/00003495-199346050-00002 · Cited by 21
Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall
Bini, A., & Kudryk, B. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51604.x · Cited by 20
Coronary Atherosclerosis and Thrombosis Underlying Acute Myocardial infarction
Saffitz, J. E., & Schwartz, C. J. (1987) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30563-0 · Cited by 18
A viscometric method of measuring plasma fibrinogen concentrations.
Ernst, E., Resch, K. L., Saradeth, T., Maier, A., & Mátrai, Á. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.6.534 · Cited by 9
Cited by
The relation of body fat mass and distribution to markers of chronic inflammation
Festa, A., D'Agostino Jr, R., Williams, K., Karter, A., Mayer-Davis, E., Tracy, R., & Haffner, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801792 · Cited by 706
(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Hackam, D. G., & Anand, S. S. (2003) · JAMA · doi:10.1001/jama.290.7.932 · Cited by 550
Baer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476
“In a meta-analysis of 22 studies, plasma fibrinogen was identified as an independent risk factor for cardiovascular disease (23).”
Background
Metadata
- Authors
- Maresca, G., Di Blasio, A., Marchioli, R., & Di Minno, G.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-06
- Volume
- 19
- Issue
- 6
- Pages
- 1368-1377
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2913967451
- Cited by
- 306
- References
- 74
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.